Security Type: Common Stock
Bid 23.82
Bid Size 0
Ask 23.85
Ask Size 0
Open 23.67
Day High 24.30
Day Low 23.29
Previous Close 23.85
52-Week High 28.212
52-Week Low 13.92
Price Performance (Last 52 Weeks)
+42.62%
Volume 0
90-Day Average Volume 65,139
Primary Exchange NASDAQ-NMS
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Options
Yes

Detailed Quote

CompareChart Options
Compare and Chart Options tabs. Compare tab selected.
 
S&P 500
DJIA
NASDAQ
Industry
Chart
 

News & Events

  • Show article details.

    Injunction lifted on Boston Scientific catheter product

    Reuters – 04/15/2014

    A U.S. appeals court on Tuesday lifted a preliminary injunction on Boston Scientific Corp's (BSX) catheter product Guidezilla that had been issued by a lower court as part of a patent fight with Vascular Solutions Inc. The U.S. Court of Appeals for the Federal Circuit, which specializes in patent appeals, said, "There are too many unresolved issues at this stage of the case" to warrant the grant of a...

  • Show article details.

    Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit

    GlobeNewswire – 04/15/2014

    Vascular Solutions, Inc. (VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the preliminary injunction that was previously issued by the District Court for the District of Minnesota effective January 13, 2014 against Boston Scientific's Guidezilla guide extension catheter.

  • Show article details.

    Injunction lifted on Boston Scientific catheter product Guidezilla

    Reuters – 04/15/2014

    A U.S. appeals court has lifted a preliminary injunction placed on Boston Scientific Corp's (BSX) catheter product Guidezilla by a lower court, as part of a patent fight with Vascular Solutions Inc. The U.S. Court of Appeals for the Federal Circuit, which specializes in patent appeals, lifted the injunction on Tuesday saying that "there are too many unresolved issues at this stage of the case" to war...

  • Show article details.

    BRIEF-U.S. appeals court lifts injunction that had favored Vascular Solutions, concerning Boston Scientific catheter

    Reuters – 04/15/2014

    * U.S. appeals court rules against Vascular Solutions Inc (VASC) throws out. preliminary injunction against Boston Scientific Corp (BSX) -- court ruling * Federal circuit court of appeals says there are too many unresolved issues to. warrant a preliminary injunction related to guidezilla guide extension. catheter * Boston scientific had challenged injunction blocking the sale of its. guidezilla catheter whi...

  • Show article details.

    Vascular Solutions Surpasses 50,000 Successfully Reprocessed ClosureFAST(R) Catheters

    GlobeNewswire – 04/09/2014

    -- Reprocessing of popular vein treatment catheter results in significant cost savings and reduced medical waste for U.S. vein clinics -- Excellent safety record established, with no serious adverse patient events reported since reprocessing began in January of 2012  -- Vascular Solutions (VASC) offers a complete package of accessory products for ClosureFAST vein ablation procedures MINNEAPOLIS, Apr...

Events

  • Apr
    22

    VASC to announce Q1 earnings After Market (Confirmed)

  • Apr
    22

    VASC Earnings Conference Call at 4:30 PM Listen

More News & Events

Company Profile

Log in for more information

Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide.

Sector (GICS®)

Health Care

Environmental, Social & Governance Summary (ESG)

  Secure. Log in required.

ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Learn more

Accounting & Governance Risk Score (AGR®)

  Secure. Log in required.

The GMI Accounting and Governance Risk (AGR®) Score & Rating is widely recognized as an indicator of the confidence level surrounding a company's management and reported financials. Learn more

About Environmental, Social & Governance Summary (ESG)

GMI ESG Ratings

Environmental, Social, and Governance (ESG) Flags: GMI Ratings publishes Environmental, Social and Governance (ESG) ratings on over 6,000 companies worldwide. These ratings provide an independent assessment of the sustainable investment value of public companies. The ESG Ratings model is based on a carefully crafted and applied list of KeyMetrics® that result in an overall ESG concern level as expressed by Red (High Concern), Yellow (Average Concern), and Green (Low Concern) flags. Unlike traditional ESG risk models, GMI's rating methodology is designed to identify risks most likely to affect equity valuations. Specifically, these ratings reflect actual corporate behaviors rather than policies or affirmations of intent to adhere to best ESG practices. Further, unlike other models with evenly weighted metrics, we assign context-sensitive relative weightings to our key metrics, based on market, regional, ownership or sector differences. Individual company scores are then assigned as a percentile rank, ranging from 1 (worst ranked) to 100 (best) on the basis of these KeyMetrics® and then converted to the Red, Yellow or Green flag designation.

Company Reports: In addition to a company's overall risk rating, ESG reports also include an industry rating based on a comparison between the company's risk levels in each ESG component area relative to its industry peers. Further, the ESG analysis serves as a summary of behavioral events that contributed to the company's overall risk level.

More About GMI

GMI Accounting and Governance Risk (AGR) Score & Rating

The GMI Accounting and Governance Risk (AGR) Score & Rating is widely recognized as an indicator of the confidence level surrounding a company's management and reported financials.

Scores range from 0 to 100, and correspond to a risk classification for each company ranging from "Very Aggressive" to "Conservative." The AGR Score is a percentile ranking among the approximately 8,000 companies rated by GMI. Through continued back-testing, GMI has demonstrated a strong correlation between its quarterly AGR Score and the likelihood of adverse events, including securities class action litigation, financial restatements, regulatory enforcement actions, and stock price declines. Thus, a company's AGR Score can help investors looking to manage risk or enhance investment performance. GMI forensically analyzes the financial reporting and governance practices of over 8,000 North American-based publicly traded companies.

About GMI

GMI is an independent risk research firm which provides a statistically modeled assessment of corporate integrity. Founded in 2002 in direct response to the growing number of scandals, lawsuits and investor losses resulting from fraudulent corporate behavior, the firm identifies potential high-risk company accounting and governance activity, which in turn has been historically correlated to stock price declines, securities class-action litigation, and material financial restatements. The product of GMI's analysis is a unique risk measure - the AGR Score which can be used by investors as a way to more effectively manage corporate risk.

More About GMI

Full Time Employees: 406

Executives  Secure. Log in required.

www.vascularsolutions.com

6464 Sycamore Court North
Minneapolis, MN 55369
United States of America

1-763-656-4300

Analyst Opinions

The Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More....

Log in to view the Equity Summary Score for VASC

Research Reports

Company Research Highlights® Report (PDF) Requires Login.

This generated report* compiles independent, third-party information highlighting key fundamental and technical data, analyst opinions, stock price movement, earnings data, and industry comparisons. Available only to Fidelity customers.

S&P Capital IQ ® Company Report Requires Login.

This generated report* has historical data on financials with interactive charts, technical indicators, and five-year peer comparison trend charts.

*Generated reports are built dynamically when you select them. Reports may not be available for some symbols. Select the link to check availability for this symbol.

VASC Industry Comparison:

VASCIndustry AveragePercentile
in Industry
Market Capitalization$408.48M$7.08B65th
Beta (1 Year Annualized)1.280.8313rd
EPS (TTM)
 
$0.65$2.9975th
Current Consensus EPS Estimate$0.18----
EPS Growth
(TTM vs. Prior TTM)
8.20%-3.11%55th
P/E (TTM)
35.8533.0090th
Dividend Yield (Annual)--1.73%--
Total Revenue (TTM)
$110.50M$9.01B63rd
Revenue Growth
(TTM vs Prior TTM)
+12.31%+6.10%66th
Shares Outstanding17,127,000523,359,16824th
Shares Short*
344.63K----
Institutional Ownership54.96%78.35%52nd

* Short Interest data provided by NASDAQ, NYSE, or AMEX and is updated periodically and on a bi-monthly basis (depending on the listing exchange).

† The Equity Summary Score provided by StarMine is current as of the date specified. There may be differences between the Equity Summary Score analyst count and the number of underlying analysts listed. Due to the timing in receiving ratings changes into the Equity Summary Score model, the Equity Summary Score analyst count may lag the ratings count displayed by one or more days. There may also be analyst count variations for symbols with multiple share classes and ADRs. More details on Equity Summary Score calculation are included in the Understanding and Using the Equity Summary Score Methodology (PDF).

As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.